Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alterations in lipid kinetics in men with HIV-dyslipidemia.
Reeds DN, Mittendorfer B, Patterson BW, Powderly WG, Yarasheski KE, Klein S. Reeds DN, et al. Among authors: powderly wg. Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E490-7. doi: 10.1152/ajpendo.00118.2003. Epub 2003 May 13. Am J Physiol Endocrinol Metab. 2003. PMID: 12746213 Free article.
Insulin resistance in HIV protease inhibitor-associated diabetes.
Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG. Yarasheski KE, et al. Among authors: powderly wg. J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):209-16. doi: 10.1097/00126334-199907010-00005. J Acquir Immune Defic Syndr. 1999. PMID: 10421244 Free PMC article.
Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia.
Yarasheski KE, Tebas P, Claxton S, Marin D, Coleman T, Powderly WG, Semenkovich CF. Yarasheski KE, et al. Among authors: powderly wg. Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E899-905. doi: 10.1152/ajpendo.00036.2003. Epub 2003 Jul 1. Am J Physiol Endocrinol Metab. 2003. PMID: 12837664 Free article. Clinical Trial.
Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.
Tebas P, Yarasheski K, Henry K, Claxton S, Kane E, Bordenave B, Klebert M, Powderly WG. Tebas P, et al. Among authors: powderly wg. AIDS Res Hum Retroviruses. 2004 Jun;20(6):589-94. doi: 10.1089/0889222041217374. AIDS Res Hum Retroviruses. 2004. PMID: 15242534 Clinical Trial.
282 results